Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
Clinical trial NCT00001790 · COMPLETED
Trial details
- NCT number
- NCT00001790
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1998-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.